Literature DB >> 3800152

Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine.

D W Cockcroft, K Y Murdock, J Kirby, F Hargreave.   

Abstract

Previous data have indicated that airway responsiveness to allergen, expressed as the provocation concentration causing a 20% FEV1 fall (PC20), was dependent on nonallergic airway responsiveness (histamine PC20) and sensitivity to allergen (skin sensitivity or end-point titration). From retrospective data in 24 subjects, we developed a formula to predict allergen PC20 and examined its accuracy prospectively in 26 new subjects undergoing allergen inhalation test with doubling allergen concentrations. Allergen PC20 (APC20) was predicted from histamine PC20 (HPC20) and skin sensitivity (SS) by the formula: Log10 (APC20) = 0.69 Log10 (HPC20 X SS) + 0.11 (r = 0.85). Allergen PC20 was accurately predicted in 6, and overestimated or underestimated by 1 doubling concentration in 11, by 2 concentrations in 6, by 3 concentrations in 3, and by greater than 3 concentrations in none. From the total of 50 subjects, a new relationship was developed: Log10 (APC10) = 0.68 log10 (HPC20 X SS) (r = 0.82) from which 46 of 50 (92%) of allergen PC20 values fall within 2 doubling concentrations of the regression line (and all within 3). Early airway responsiveness to a given allergen can be predicted within a +/- 8-fold range, which is better than some investigator's test reproducibility of +/- 1 log (10-fold). Allergen inhalation tests to determine early asthmatic responsiveness to different IgE-mediated allergens can probably be replaced by the simpler and safer determinations of allergen sensitivity (SS, RAST) and histamine or methacholine airway responsiveness.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3800152     DOI: 10.1164/arrd.1987.135.1.264

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  21 in total

Review 1.  Understanding allergic asthma from allergen inhalation tests.

Authors:  Donald W Cockcroft; Fredrick E Hargreave; Paul M O'Byrne; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2007-10       Impact factor: 2.409

2.  Ventilation and perfusion lung scintigraphy of allergen-induced airway responses in atopic asthmatic subjects.

Authors:  Krishnan Parameswaran; Andrew C Knight; Niall P Keaney; E David Williams; Ian K Taylor
Journal:  Can Respir J       Date:  2007 Jul-Aug       Impact factor: 2.409

3.  Perception of breathlessness during bronchoconstriction induced by antigen, exercise, and histamine challenges.

Authors:  H Turcotte; F Corbeil; L P Boulet
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

4.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation.

Authors:  J R Brown; J Kleimberg; M Marini; G Sun; A Bellini; S Mattoli
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

5.  Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.

Authors:  A L Hamilton; R M Watson; G Wyile; P M O'Byrne
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 6.  Occupational reactions in the seafood industry.

Authors:  J L Malo; A Cartier
Journal:  Clin Rev Allergy       Date:  1993

7.  Occupational asthma and rhinitis induced by a herbal medicine, Wonji (Polygala tenuifolia).

Authors:  Hye-Kyung Park; Seong-Gyu Jeon; Tae-Bum Kim; Hye-Ryun Kang; Yoon-Seok Chang; Yoon-Keun Kim; Sang-Heon Cho; Kyung-Up Min; You-Young Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

8.  Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sample.

Authors:  B G Higgins; J R Britton; S Chinn; K K Lai; P G Burney; A E Tattersfield
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

9.  Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation.

Authors:  Roma Sehmi; Sandra Dorman; Adrian Baatjes; Rick Watson; Ronan Foley; Sun Ying; Douglas S Robinson; A Barry Kay; Paul M O'Byrne; Judah A Denburg
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

10.  Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.

Authors:  A Freitag; R M Watson; G Matsos; C Eastwood; P M O'Byrne
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.